The U.S. Food and Drug Administration took steps for expanded communication on the serious risk of opioids to outpatient patients and healthcare professionals.

Drugs derived from an active ingredient in marijuana produced only modest increases in pain threshold and tolerance but no reduction in ongoing intensity.

Pharmaceutical companies may be engaging in price gouging, with costs rising at double the normal rate when drugs are in limited supply, a study claims.

The U.S. Food and Drug Administration on Tuesday launched a new ad campaign aimed at curbing rampant e-cigarette use among American teens.

People with body mass index of 30 or higher need intensive behavioral interventions, including diet changes and more physical activity, according to the USPSTF.

A new survey shows that nearly a third of high school e-cig users have vaped marijuana.

Lumoxiti injection has been approved for certain instances of relapsed or refractory "hairy cell" leukemia, the U.S. Food and Drug Administration said Thursday

The FDA has warned that it found a second impurity in Torrent Pharmaceuticals' valsartan products, which are used for high blood pressure and heart failure.

With roughly 40 percent of Americans now obese, new research finds that one strategy may be helping Americans stay slim: calorie counts on restaurant menus.

People who took recalled blood pressure drugs containing a carcinogen do not appear to have a markedly increased short-term risk of cancer, a new study reports.

Government-funded research is helping scientists find new ways to prevent, detect, diagnose and treat cancer, the AACR reports, but increased funding is needed.

Weight-loss and energy supplements in the U.S. may contain potentially harmful and inaccurately labeled levels of the banned stimulant higenamine, a study finds.

U.S. Food and Drug Administration issued stern warning to electronic cigarette makers: control "epidemic" use by teens or products will be banned for everyone.

Cassipa, a combination of buprenorphine and naloxone, a film designed to be placed under the tongue, has been approved to treat opioid dependence, the FDA announced.

An experimental single-dose flu drug shows promise as a new way to alleviate the misery of influenza, researchers say.